DK1185293T3 - IL6RIL6-kimær til behandling af neurodegenerative sygdomme - Google Patents

IL6RIL6-kimær til behandling af neurodegenerative sygdomme

Info

Publication number
DK1185293T3
DK1185293T3 DK00939022T DK00939022T DK1185293T3 DK 1185293 T3 DK1185293 T3 DK 1185293T3 DK 00939022 T DK00939022 T DK 00939022T DK 00939022 T DK00939022 T DK 00939022T DK 1185293 T3 DK1185293 T3 DK 1185293T3
Authority
DK
Denmark
Prior art keywords
treatment
neurodegenerative diseases
il6ril6 chimera
il6ril6
chimera
Prior art date
Application number
DK00939022T
Other languages
English (en)
Inventor
Ursula Boschert
Michel Revel
Judith Chebath
Marina Pizzi
Pierfranco Spano
Original Assignee
Yeda Res & Dev
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Applied Research Systems filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK1185293T3 publication Critical patent/DK1185293T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00939022T 1999-06-21 2000-06-21 IL6RIL6-kimær til behandling af neurodegenerative sygdomme DK1185293T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13058699A IL130586A0 (en) 1999-06-21 1999-06-21 IL6RIL6 chimera for the treatment of demyelinating diseases

Publications (1)

Publication Number Publication Date
DK1185293T3 true DK1185293T3 (da) 2005-12-27

Family

ID=11072949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00939022T DK1185293T3 (da) 1999-06-21 2000-06-21 IL6RIL6-kimær til behandling af neurodegenerative sygdomme

Country Status (21)

Country Link
US (1) US7201896B1 (da)
EP (1) EP1185293B1 (da)
JP (1) JP4846148B2 (da)
KR (1) KR100678290B1 (da)
CN (1) CN1164328C (da)
AT (1) ATE306280T1 (da)
AU (1) AU778662B2 (da)
BR (1) BR0011363A (da)
CA (1) CA2374997C (da)
DE (1) DE60023139T2 (da)
DK (1) DK1185293T3 (da)
EA (1) EA004626B1 (da)
EE (1) EE05559B1 (da)
ES (1) ES2250140T3 (da)
HK (1) HK1047549A1 (da)
IL (2) IL130586A0 (da)
MX (1) MXPA02000116A (da)
NO (1) NO329028B1 (da)
UA (1) UA76695C2 (da)
WO (1) WO2000078331A2 (da)
ZA (1) ZA200109488B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1317273T3 (da) 2000-09-14 2006-09-04 Ares Trading Sa Anvendelse af IL-6R/IL-6-kimærer mod Huntingtons sygdom
DE10107737A1 (de) * 2001-02-16 2002-09-05 S Rose John Christian Albrecht Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie
CN100405062C (zh) * 2001-04-10 2008-07-23 利兰·斯坦福青年大学托管委员会 抗体特异性分布的治疗和诊断使用
IL147412A0 (en) * 2001-12-31 2002-08-14 Yeda Res & Dev The use of il6r/il6 chimera in nerve cell regeneration
WO2004111210A1 (en) * 2003-06-12 2004-12-23 Yeda Research & Development Co.Ltd Enhancement of oligodendrocyte differentiation
US20070071727A1 (en) * 2003-11-14 2007-03-29 Olsson Mats J Melanocytes in therapy of neurodegenerative diseases
IL161672A0 (en) * 2004-04-29 2004-09-27 Yeda Res & Dev Compositions and methods for therapy of chemotherapy-induced neuropathy
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
JP2019511261A (ja) * 2016-02-12 2019-04-25 エイエルエス・セラピー・デベロップメント・インスティテュートＡＬＳ Ｔｈｅｒａｐｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｉｎｓｔｉｔｕｔｅ 運動データに基づいたａｌｓの進行の測定
WO2018056412A1 (ja) * 2016-09-23 2018-03-29 国立大学法人大阪大学 シュワン細胞分化促進剤及び末梢神経再生促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
JPH1148413A (ja) 1997-08-06 1999-02-23 Dainippon Printing Co Ltd ホルムアルデヒド捕捉壁紙およびその製造方法
JP4859153B2 (ja) * 1999-02-25 2012-01-25 東ソー株式会社 新規神経系細胞分化促進剤

Also Published As

Publication number Publication date
EA200200063A1 (ru) 2002-06-27
NO20015673D0 (no) 2001-11-20
ATE306280T1 (de) 2005-10-15
MXPA02000116A (es) 2003-07-21
EP1185293B1 (en) 2005-10-12
EE05559B1 (et) 2012-08-15
DE60023139D1 (de) 2006-02-23
ZA200109488B (en) 2002-11-18
NO329028B1 (no) 2010-08-02
CA2374997C (en) 2010-04-13
HK1047549A1 (en) 2003-02-28
ES2250140T3 (es) 2006-04-16
NO20015673L (no) 2001-12-17
AU5423100A (en) 2001-01-09
KR100678290B1 (ko) 2007-02-05
IL130586A0 (en) 2000-06-01
CA2374997A1 (en) 2000-12-28
CN1164328C (zh) 2004-09-01
BR0011363A (pt) 2002-02-26
EA004626B1 (ru) 2004-06-24
WO2000078331A3 (en) 2001-07-05
JP2003502382A (ja) 2003-01-21
IL147188A (en) 2015-09-24
KR20020013901A (ko) 2002-02-21
US7201896B1 (en) 2007-04-10
JP4846148B2 (ja) 2011-12-28
DE60023139T2 (de) 2006-05-04
CN1364088A (zh) 2002-08-14
AU778662B2 (en) 2004-12-16
UA76695C2 (uk) 2006-09-15
EP1185293A2 (en) 2002-03-13
EE200100689A (et) 2003-02-17
WO2000078331A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
NO20034056D0 (no) Proliferative sykdommer
ATE377592T1 (de) Neurotropische substituierte pyrimidine
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DK1304992T3 (da) Topisk gel-fremföringssystem til behandling af hudlidelser
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
MXPA02012626A (es) Bis-arilsufonas.
IL171384A (en) Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders
DK1185293T3 (da) IL6RIL6-kimær til behandling af neurodegenerative sygdomme
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
PT1135134E (pt) Utilizacao de estimuladores do factor neurotrofico para o tratamento de doencas oftalmicas neurodegenerativas
CA2534303A1 (en) Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DE60124791D1 (de) S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
DE60017136D1 (de) Behandlung von angiogenese-abhängigen erkrankungen mit dextrinsulphat
SI1185293T1 (sl) Uporaba himer il6ril6 za zdravljenje nevrodegenerativnih bolezni